Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-market, Prospective, Randomised, Controlled, Masked Clinical Investigation to Compare the Safety and Efficacy of Ophtesis Bio 3% With a Similar 3% Sodium Hyaluronate OVD (Ophthalmic Viscosurgical Device)

NCT05832749 is registered in ClinicalTrials.gov with Gemini Eye Clinic as lead sponsor.

NCT NCT05832749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05832749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-market, Prospective, Randomised, Controlled, Masked Clinical Investigation to Compare the Safety and Efficacy of Ophtesis Bio 3% With a Similar 3% Sodium Hyaluronate OVD (Ophthalmic Viscosurgical Device)
Lead sponsor
Gemini Eye Clinic
Phase
Observational
Overall status
Unknown status
Start date
August 23, 2022
Completion date
May 31, 2023
Enrollment
296 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bilateral cataract, unilateral cataract